Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review

International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ekaterina I. Alekseeva (Author), Dariya D. Van'kova (Author), Margarita A. Soloshenko (Author), Tatyana M. Dvoryakovskaya (Author), Kseniya B. Isaeva (Author), Rina V. Denisova (Author), Anna V. Mamutova (Author), Aleksandra M. Chomahidze (Author), Nikolay A. Mayanskiy (Author), Natalya E. Tkachenko (Author)
Format: Book
Published: "Paediatrician" Publishers LLC, 2019-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:International practice of immunization against pneumococcus in patients with systemic juvenile idiopathic arthritis (SJIA) receiving biological therapy is generalized in this review. High efficiency and safety of pneumococcal vaccines in children with SJIA is presented. Numerous researches show the adequate immune response after vaccination as well as alongside with genetically engineered biologic drugs therapy. Prevention of pneumococcal disease in patients with SJIA reduces the risk of development of pneumococcal diseases severe complications.
Item Description:1682-5527
1682-5535
10.15690/vsp.v18i2.2012